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Abstract
Introduction: Aggressive fibromatosis is a benign tumor, thought to arise from deep musculoaponeurotic
structures, rarely found in the head or neck. However, when it does occur in the head and neck region, it tends to
be more aggressive and associated with significant morbidity, which may be attributed to the vital vascular,
neurological or anatomical structures in close proximity.
Case presentation: We report the case of a 39-year-old Pakistani man who presented with a two-month history of
a lump on the right side of his neck. The mass was excised and histopathological analysis revealed a case of
aggressive fibromatosis.
Conclusion: Due to the rarity of the condition no guidelines are available on the indications and extent of each
modality. Due to its aggressive behavior and tendency to invade local structures and recur, a multi-modality
management strategy is usually employed. On the basis of this case, we suggest that aggressive surgery is a viable
management option and may be successfully used as a single modality treatment.
Introduction
Aggressive fibromatosis (AF) is a benign tumor, thought
to arise from deep musculoaponeurotic structures [1],
characterized by local invasion and recurrence that can
occur anywhere in the body. It has rarely been reported
in the head and neck region, with 179 cases documented
between 1968 and 2008.
Due to the tendency of AF to invade local structures
and recur, a multi-modality management strategy is
usually employed. However due to its rarity in the head
and neck, no guidelines are available on the indications
and extent of each modality. Here we report a case of AF
of the neck successfully managed by wide surgical exci-
sion; with no signs of recurrence 22 months after surgery.
Case presentation
A 39-year-old Pakistani man had presented to our Gen-
eral Surgery clinic with a two-month history of a lump
on the right side of his neck. There were no associated
symptoms. There was no history of tobacco or irritant
use. On physical examination a fixed mass, 4 cm in size,
was palpated in right level III. It was not associated with
any changes in the overlying skin. An examination of
his upper aerodigestive tract was unremarkable. The
mass was excised by a general surgeon. Histopathologi-
cal analysis demonstrated spindle-shaped cells with no
identifiable nuclear pleomorphism or mitotic activity.
The cells stained positive for anti-smooth muscle actin
(ASMA), favoring a smooth muscle origin.
The mass, however, recurred within a period of one
month and continued to increase in size, limiting his
neck movement to the right side. On presentation to
our Head and Neck Surgery clinic, a hard, well demar-
cated, non-tender and non-mobile mass of about 5 × 8
cm was noticed in the posterior triangle.
A computed tomography (CT) scan of his neck
showed a large soft tissue mass in his right posterior
neck, measuring about 6.5 × 4.7 cm in its greatest
dimension, involving both his anterior and posterior sca-
lene muscles and closely abutting the right lobe of his
thyroid gland. On the anterior side it extended up to his
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sternocleidomastoid muscle (SCM). Splaying of his right
internal jugular vein was also noted between the SCM
and the mass. Multiple sub-centimeter lymph nodes
were also noted at level II. Fine-needle aspiration cytol-
ogy (FNAC) showed spindle shaped cells with elongated
vesicular nuclei and pink cytoplasm admixed with pink
fibrocollagenous material suggestive of fibromatosis.
Our patient underwent a wide local excision with a
right-sided neck dissection.
Histopathological analysis of the excised tissue showed
spindle cells arranged in sheets and intersecting fascicles
with variable collagen deposition. No cytological atypia
was noted; however, infiltrative growth was noticed
within the entrapped skeletal muscle at the periphery.
The lesion showed evidence of vascular proliferation
and peripheral lymphocytic infiltration. The above find-
ings correlated with a tissue diagnosis of AF.
Our patient once again presented with local recur-
rence of the mass [Figure 1], not associated with any
pain or tenderness, but with complaints of suffocation
when lying supine, due to a pressure effect generated by
the mass [Figure 1].
Magnetic resonance imaging (MRI) showed a large
contrast-enhancing mass, hypointense on T1 and hyper-
intense on T2, lying in the lower part of his neck to the
right of the midline. It was deep to the SCM on the
anterior side, abutting the larynx medially and the para-
vertebral muscles and space on the posterior side [Fig-
ure 2]. A CT scan showed a large soft tissue density
mass measuring about 9.3 × 5.9 × 12 cm, with central
necrosis consistent with recurrent fibromatosis in the
posterior triangle [Figure 3].
The mass was resected and an extended right neck dis-
section was performed. Analysis of the excised tissue
revealed spindle cells arranged in whorls and fascicles,
with intervening thin walled vessels and extravasation of
red blood cells. There was no evidence of atypical mitosis
or necrosis; however, focal infiltration of adjacent muscle
was noted, favoring benign fibromatosis [Figure 4].
Our patient was followed in the out-patient clinic reg-
ularly for 22 months with no evidence of recurrence of
disease. No further treatment was given.
Discussion
AF in the head and neck is a rare benign tumor,
thought to arise from connective tissue, fascial sheaths,
and other musculoaponeurotic structures of the body
[1]. It presents as a progressively enlarging painless
lump, fixed to the underlying structures. By virtue of its
location it may be associated with trismus, airway
obstruction, dysphagia, and proptosis [2]. Intermittent
airway obstruction due to pressure effects and gravita-
tional position may also occur, as was noted in our case.
AF is a slow growing tumor; as such it demonstrates a
low level of mitosis and cellular atypia, and distant
metastasis has yet to be reported. Its true pathogenic
potential lies in its ability to locally invade surrounding
structures. This fact is of extreme importance in the
head and neck region due to the compact anatomical
schematics and close association with vital neurovascu-
lar and anatomical structures; however invasion of the
neurovascular structures has not been reported [3].
Kruse et al. proposed a classification for AF in the
head and neck after reviewing cases reported in the last
40 years, based on the site (such as upper and lower
compartment), bone involvement and presence of hor-
mone receptors [3]. In their review they found no indi-
cators for potential recurrence in relation to age, sex, or
localization [3], but the depth of invasion was shown to
significantly affect disease-free survival [4].
The main treatment modality is wide surgical excision
of the lesion, however in the head and neck region pre-
servation of vital structures and their function may
impede this objective [5]. Therefore a multi-modality
management strategy is usually employed to control
residual disease. Surgery is usually combined with radia-
tion therapy for control of residual disease and to pre-
vent recurrence.
Studies have shown that radiation therapy can also be
effectively employed independently, leading to a com-
plete response in 20%, a partial response in 20%, and
stable disease in 53% of cases; supporting evidence that
radiation therapy may decrease indications for surgery
[6]. In cases of patients undergoing multi-modality treat-
ment, including surgical resection and radiation therapy,
Figure 1 39-year-old male with a right sided neck mass. Scars from previous excisions are seen. The reccurring mass on examination.
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the recurrence free survival rate is 83.6% at five years
[6], with figures going up to 88.5% for 10-year recur-
rence free survival [7].
However, radiation therapy is associated with a high
risk of complications, especially in the head and neck
region, and in our opinion should only be considered in
cases with residual disease or where surgery may signifi-
cantly impair the functional capabilities of the patient.
Although it is argued that chemotherapy is not effec-
tive in benign tumors with low mitotic rates, cases of
AF successfully treated with cytotoxic and non-cytotoxic
chemotherapy are being reported. Sze et al. report sig-
nificant tumor shrinkage with low dose methotrexate
and vinblastine [1]. Another trial concluded that pegy-
lated liposomal doxorubicin leads to tumor shrinkage
and partial remission in some cases; or at least stops
proliferation, leading to a stable disease state [8]. Melox-
icam, a COX-2 inhibitor, has also been shown to be
effective in controlling extra-abdominal AF [9]. Keeping
these in mind, pharmacological therapy can be consid-
ered for unresectable disease, or in cases where surgical
and radiation therapy may lead to significant morbidity.
Janis et al., in their review on pharmacological manage-
ment of AF, concluded that although chemotherapy is
effective against AF, larger trials are required to validate
their results [10]. Sarcoma Alliance for Research
through Collaboration (SARC) initiated a multi-center
phase II trial on the efficacy of imatinib in AF and esti-
mated progression-free survival was 94% and 88%, for
two and four months respectively; whereas one year
progression-free survival was 66% [11].
Recently radio frequency ablation has also been advo-
cated by Ilaslan et al., with no recurrence noted after a
mean follow-up of 30 months [12]. Early data from the
Mayo Clinic, USA shows that percutaneous cryoablation
may provide an alternative treatment for small to middle
sized tumors [13]. However, both modalities have been
recently tried on a limited number of patients and it is
too early to comment on their application.
Conclusion
The rarity of AF in the head and neck means that no
guidelines are currently available on the indications and
extent of each modality. Due to the aggressive behavior
and tendency to invade local structures and recur, a
multi-modality management strategy is usually
employed. On the basis of this case, the authors suggest
that aggressive surgery is a viable management option
for AF in the head and neck, and may be successfully
used as a single modality treatment. However where
functional preservation and aesthetics need to be taken
into account, a multi-modality treatment plan involving
chemotherapy and radiation therapy can be considered
for its management.
Figure 2 Axial (A) and sagittal (B) T1 MRI scans with contrast showing the mass.
Figure 3 Coronal (A), axial (B) and sagittal (C) CT scans with contrast showing the mass measuring about 9.3 × 5.9 × 12 cm with areas
of central necrosis. The carotid sheath is displaced anteriorly.
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Consent
Written informed consent was obtained from the patient
for publication of this case report and any accompany-
ing images. A copy of the written consent is available
for review by the Editor-in-Chief of this journal.
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Figure 4 Histopathological examination of the excised tissue. (A) Fibrosarcoma arising in a background of dermatofibrosarcoma protuberans
showing proliferation of spindle cells with a prominent storiform pattern and cells exhibiting pleomorphism with increase mitotic activity (H&E,
10 ×). (B) Fibromatosis showing proliferation of bland spindle shaped cells with infiltration into the muscle at the periphery and perivascular
lymphocytic infiltrate (H&E, 10 ×).
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